Physical changes within a cancer cells' local environment play in the aggressiveness of breast cancer.
Breast cancer is the most commonly diagnosed cancer in women- one in eight (12.4 percent) in the U.S. will be diagnosed with it. Invasive breast cancer is dangerous for two reasons: It can aggressively spread to other organs in the body, and it is likely to recur. While treatable in the early stages via surgery or chemotherapy, as the disease progresses, the chances of recovery decrease exponentially.
Inflammatory Breast Cancer
One of the rare breast cancers, inflammatory breast cancer is marked by redness, swelling and warmth of the breast skin looking like an orange peel.
Advertisement
‘An increase of tissue stiffness and rigidity by the local surrounding cells may lead to tumor aggressiveness and cause it to spread to other organs.’
Tweet it Now
Many of the drugs and therapies available today target breast cancer cells but tend to neglect the surrounding "local environment," which includes surrounding tissues. But cancer cells and their local environment are connected, so both undergo striking chemical and physical changes during tumor development.
"Prior attempts to clarify the interactions between breast cancer cells and the local environment ... were mainly done on artificial smooth surfaces ... and yield misleading indications," Parikh said.
![Triple-Negative Breast Cancer]( "Triple-Negative Breast Cancer")
Triple-negative breast cancers are ER negative, PR negative, and lack overexpression of HER-2. They are difficult to treat and are very aggressive.
"I'm studying how the cancerous microenvironment -- especially the physical attributes of tissue stiffness and rigidity -- controls cancer progression."
During tumor development, "the local environment undergoes significant chemical and physical alterations that are regulated by both cancer cells and the cells surrounding the tumor," Parikh said.
Based on clinical observations, an increase of tissue stiffness and rigidity is among the most profound of these physical changes. "More importantly, clinical data suggests that increased stiffness may lead to tumor aggressiveness and cause it to spread to other organs," Parikh said.
As a better way to explore the role of tissue stiffness in cancer aggressiveness -- independent of the chemical alterations --, Parikh and colleagues developed a biomimetic platform that mimics the stiffness of the local environment from healthy "soft" breast tissue to cancerous "stiff" tissue.
"Our platform is easy to manipulate and can be tuned to accommodate a range of stiffness that corresponds to the gradual changes that occur during cancer development," Parikh said. "It allows us to encode the complex correlation between tissue stiffness and cancer development."
Culturing breast cancer cells on surfaces of different stiffness resulted in cells with different biological structures. "The cells inclined toward being more aggressive -- metastatic (spreading to other organs) -- as stiffness increased," Parikh said.
"Strikingly, the data obtained after three and seven days' culture was significantly different than previous studies carried out for less than 24 hours. Also, with increased stiffness, the drug resistance of the breast cancer cells increased -- which suggests that drugs designed to target merely at a cellular level are not enough."
This new approach to cancer therapeutics offers significant promise for future drug development. "Developing drugs that can potentially prevent an increase in stiffness can most likely stop the spread of cancer," Parikh said. "Localizing it would allow it to be easily removed using surgical techniques."
Source: Eurekalert
Triple-Negative Breast Cancer
Triple-negative breast cancers are ER negative, PR negative, and lack overexpression of HER-2. They are difficult to treat and are very aggressive.
Advertisement
"I'm studying how the cancerous microenvironment -- especially the physical attributes of tissue stiffness and rigidity -- controls cancer progression."
During tumor development, "the local environment undergoes significant chemical and physical alterations that are regulated by both cancer cells and the cells surrounding the tumor," Parikh said.
Based on clinical observations, an increase of tissue stiffness and rigidity is among the most profound of these physical changes. "More importantly, clinical data suggests that increased stiffness may lead to tumor aggressiveness and cause it to spread to other organs," Parikh said.
As a better way to explore the role of tissue stiffness in cancer aggressiveness -- independent of the chemical alterations --, Parikh and colleagues developed a biomimetic platform that mimics the stiffness of the local environment from healthy "soft" breast tissue to cancerous "stiff" tissue.
"Our platform is easy to manipulate and can be tuned to accommodate a range of stiffness that corresponds to the gradual changes that occur during cancer development," Parikh said. "It allows us to encode the complex correlation between tissue stiffness and cancer development."
Culturing breast cancer cells on surfaces of different stiffness resulted in cells with different biological structures. "The cells inclined toward being more aggressive -- metastatic (spreading to other organs) -- as stiffness increased," Parikh said.
"Strikingly, the data obtained after three and seven days' culture was significantly different than previous studies carried out for less than 24 hours. Also, with increased stiffness, the drug resistance of the breast cancer cells increased -- which suggests that drugs designed to target merely at a cellular level are not enough."
This new approach to cancer therapeutics offers significant promise for future drug development. "Developing drugs that can potentially prevent an increase in stiffness can most likely stop the spread of cancer," Parikh said. "Localizing it would allow it to be easily removed using surgical techniques."
Source: Eurekalert
Screening for Breast Cancer with Clinical Breast Examination
Clinical breast examination is a simple and inexpensive method of detecting breast cancer especially in women who do not have access to mammography.
Advertisement
 Male Breast CancerMost cases of male breast cancer are diagnosed between the ages of 60 and 70 years. Treatment of male breast cancer often involves surgery. | Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
In patients with breast cancer combination therapy had increased invasive disease-free survival compared to those who were treated with the hormone therapy alone.
An antibody treatment helped shrink tumors in some patients with bile duct cancers.
Comprehending the association between the gut microbiome and polyp growth sheds insights into potential screenings and treatments.
The first large-scale, collaborative, open analysis of genomic data provides a cloud-based resource for researchers looking for more comprehensive data on pediatric brain tumors.
The mission of Axiom Space incorporated numerous experiments focusing on human stem cell aging, inflammation, and cancer within the laboratory situated in the low Earth orbit.